JP2017106923A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017106923A5 JP2017106923A5 JP2016243869A JP2016243869A JP2017106923A5 JP 2017106923 A5 JP2017106923 A5 JP 2017106923A5 JP 2016243869 A JP2016243869 A JP 2016243869A JP 2016243869 A JP2016243869 A JP 2016243869A JP 2017106923 A5 JP2017106923 A5 JP 2017106923A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- protein
- sample
- treatment
- modulator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32571710P | 2010-04-19 | 2010-04-19 | |
| US61/325,717 | 2010-04-19 | ||
| US35649510P | 2010-06-18 | 2010-06-18 | |
| US61/356,495 | 2010-06-18 | ||
| US42117810P | 2010-12-08 | 2010-12-08 | |
| US61/421,178 | 2010-12-08 | ||
| US201161443146P | 2011-02-15 | 2011-02-15 | |
| US61/443,146 | 2011-02-15 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013506214A Division JP6158078B2 (ja) | 2010-04-19 | 2011-04-18 | 薬物感受性、薬物抵抗性および疾患進行の予測のための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017106923A JP2017106923A (ja) | 2017-06-15 |
| JP2017106923A5 true JP2017106923A5 (cg-RX-API-DMAC7.html) | 2017-09-14 |
| JP6580546B2 JP6580546B2 (ja) | 2019-09-25 |
Family
ID=44834747
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013506214A Expired - Fee Related JP6158078B2 (ja) | 2010-04-19 | 2011-04-18 | 薬物感受性、薬物抵抗性および疾患進行の予測のための組成物および方法 |
| JP2016243869A Expired - Fee Related JP6580546B2 (ja) | 2010-04-19 | 2016-12-16 | 薬物感受性、薬物抵抗性および疾患進行の予測のための組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013506214A Expired - Fee Related JP6158078B2 (ja) | 2010-04-19 | 2011-04-18 | 薬物感受性、薬物抵抗性および疾患進行の予測のための組成物および方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9766249B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2561368B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6158078B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101977875B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN102947706B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011242990B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2795362C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2650674T3 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1258688A1 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2561368T4 (cg-RX-API-DMAC7.html) |
| SG (1) | SG184507A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011133477A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102089444A (zh) | 2008-05-14 | 2011-06-08 | 德玛泰克国际公司 | 利用核酸分析方法来诊断黑素瘤和太阳能雀斑 |
| CA2767616A1 (en) | 2009-07-09 | 2011-01-13 | The Scripps Research Institute | Gene expression profiles associated with chronic allograft nephropathy |
| WO2014145705A2 (en) | 2013-03-15 | 2014-09-18 | Battelle Memorial Institute | Progression analytics system |
| CN104152397A (zh) * | 2013-05-13 | 2014-11-19 | 复旦大学 | 一种致敏动物的脾细胞模型及其在药物筛选中的用途 |
| GB201314485D0 (en) * | 2013-08-13 | 2013-09-25 | Electrophoretics Ltd | Materials and methods relating to pancreatic cancer |
| WO2015048802A2 (en) * | 2013-09-30 | 2015-04-02 | Daiichi Sankyo Co., Ltd. | Protein biomarker and uses thereof |
| WO2019161126A1 (en) | 2018-02-14 | 2019-08-22 | Dermtech, Inc. | Novel gene classifiers and uses thereof in non-melanoma skin cancers |
| WO2022187196A1 (en) * | 2021-03-02 | 2022-09-09 | Dermtech, Inc. | Predicting therapeutic response |
| US10443100B2 (en) | 2014-05-22 | 2019-10-15 | The Scripps Research Institute | Gene expression profiles associated with sub-clinical kidney transplant rejection |
| US11104951B2 (en) | 2014-05-22 | 2021-08-31 | The Scripps Research Institute | Molecular signatures for distinguishing liver transplant rejections or injuries |
| CN104745700A (zh) * | 2015-03-27 | 2015-07-01 | 南京医科大学 | 一种食管癌相关甲基化生物标志物及应用 |
| HRP20191019T1 (hr) * | 2015-07-07 | 2019-09-06 | F. Hoffmann - La Roche Ag | Kombinacijska terapija konjugatom protutijela i lijeka anti-her2 i inhibitorom bcl-2 |
| CN109072309B (zh) * | 2016-02-02 | 2023-05-16 | 夸登特健康公司 | 癌症进化检测和诊断 |
| CN105524973A (zh) * | 2016-03-15 | 2016-04-27 | 南京华奥生物医药技术有限公司 | 利用自体肿瘤与正常配对原代细胞筛选肿瘤药物的方法 |
| CN107091930B (zh) * | 2017-03-07 | 2020-09-15 | 杭州百凌生物科技有限公司 | 快速预测和提高非小细胞肺癌细胞对表皮细胞生长因子受体抑制剂敏感性的方法 |
| CN107271672B (zh) * | 2017-06-21 | 2019-01-01 | 首都医科大学附属北京友谊医院 | 外泌体p-ERK在制备结直肠癌诊断产品中的应用 |
| KR102094802B1 (ko) * | 2017-10-24 | 2020-03-31 | 고려대학교 산학협력단 | 소변 대사체 분석을 이용한 베체트병의 진단방법 |
| CN111417730A (zh) * | 2017-11-20 | 2020-07-14 | 托雷莫治疗股份公司 | 诊断方法 |
| TWI683905B (zh) * | 2017-11-21 | 2020-02-01 | 長庚醫療財團法人高雄長庚紀念醫院 | 用於檢測川崎氏病的方法及套組以及用於治療川崎氏病的方法 |
| JP2022524641A (ja) | 2019-03-26 | 2022-05-09 | ダームテック，インク． | 皮膚癌における新規な遺伝子分類子とその使用 |
| KR102199141B1 (ko) | 2019-05-03 | 2021-01-06 | 사회복지법인 삼성생명공익재단 | 대장암 진단 마커 및 대장암 진단에 필요한 정보를 제공하는 방법 |
| JP2023537260A (ja) * | 2020-07-24 | 2023-08-31 | ジェネンテック， インコーポレイテッド | バイオマーカーを使用する骨髄穿刺液の血液希釈の決定 |
| CN115267165A (zh) * | 2022-08-15 | 2022-11-01 | 海仕兰(上海)生物科技有限公司 | 一种悬浮芯片系统及其应用以及基于悬浮芯片系统对肿瘤伴随诊断因子检测方法 |
| KR20240037082A (ko) * | 2022-09-14 | 2024-03-21 | 아주대학교산학협력단 | 항암제 내성 측정용 바이오 마커 및 이를 이용한 항암제 내성 예측 정보 제공 방법 |
| CN118130793B (zh) * | 2024-02-26 | 2025-07-29 | 赣南医科大学 | 视网膜母细胞瘤的生物标志物cdk12及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6218122B1 (en) | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
| WO2006026710A2 (en) * | 2004-08-31 | 2006-03-09 | The Johns Hopkins University | Rapid prognostic assay for malignancies treated with epidermal growth factor receptor |
| KR101637140B1 (ko) | 2005-05-09 | 2016-07-06 | 테라노스, 인코포레이티드 | 현장진료 유체 시스템 및 그 용도 |
| WO2006125143A2 (en) * | 2005-05-18 | 2006-11-23 | Novartis Ag | Methods for diagnosis and treatment of proliferative disorders mediated by cd40 signaling |
| EP1904657B1 (en) * | 2005-06-08 | 2011-05-25 | Hitachi Chemical Research Center, Inc. | METHOD FOR PREDICTING IMMUNE RESPONSE TO NEOPLASTIC DISEASE BASED ON mRNA EXPRESSION PROFILE IN NEOPLASTIC CELLS AND STIMULATED LEUKOCYTES |
| ATE543914T1 (de) * | 2005-09-01 | 2012-02-15 | Bristol Myers Squibb Co | Biomarker und verfahren zur bestimmung der empfindlichkeit gegen vegfr2 modulator. |
| WO2007143183A2 (en) * | 2006-06-04 | 2007-12-13 | Soner Altiok | Methods for developing and assessing therapeutic agents |
| EP2899541A1 (en) * | 2007-03-02 | 2015-07-29 | Genentech, Inc. | Predicting response to a HER dimerisation inhbitor based on low HER3 expression |
| JP2010536371A (ja) * | 2007-08-21 | 2010-12-02 | ノダリティ，インコーポレイテッド | 診断方法、予後および治療方法 |
| ES2535631T3 (es) | 2007-10-24 | 2015-05-13 | Biomarker Strategies, Llc | Métodos y dispositivos mejorados para análisis celular |
| WO2009073513A1 (en) * | 2007-11-30 | 2009-06-11 | Schering Corporation | Braf biomarkers |
-
2011
- 2011-04-18 ES ES11772505.1T patent/ES2650674T3/es active Active
- 2011-04-18 CA CA2795362A patent/CA2795362C/en active Active
- 2011-04-18 KR KR1020127029888A patent/KR101977875B1/ko not_active Expired - Fee Related
- 2011-04-18 JP JP2013506214A patent/JP6158078B2/ja not_active Expired - Fee Related
- 2011-04-18 CN CN201180030332.9A patent/CN102947706B/zh not_active Expired - Fee Related
- 2011-04-18 AU AU2011242990A patent/AU2011242990B2/en not_active Ceased
- 2011-04-18 CN CN201810296066.8A patent/CN108535465A/zh active Pending
- 2011-04-18 EP EP11772505.1A patent/EP2561368B1/en active Active
- 2011-04-18 SG SG2012074746A patent/SG184507A1/en unknown
- 2011-04-18 PL PL11772505T patent/PL2561368T4/pl unknown
- 2011-04-18 WO PCT/US2011/032935 patent/WO2011133477A2/en not_active Ceased
- 2011-04-18 US US13/089,219 patent/US9766249B2/en not_active Expired - Fee Related
-
2016
- 2016-12-16 JP JP2016243869A patent/JP6580546B2/ja not_active Expired - Fee Related
-
2019
- 2019-01-22 HK HK19101066.6A patent/HK1258688A1/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017106923A5 (cg-RX-API-DMAC7.html) | ||
| Yankaskas et al. | A microfluidic assay for the quantification of the metastatic propensity of breast cancer specimens | |
| Liu et al. | DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways | |
| Grottke et al. | Downregulation of AKT3 increases migration and metastasis in triple negative breast cancer cells by upregulating S100A4 | |
| Sharif et al. | Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling | |
| JP2016507233A5 (cg-RX-API-DMAC7.html) | ||
| Miyamoto et al. | Single-cell analysis of circulating tumor cells as a window into tumor heterogeneity | |
| Bhandari et al. | MAL2 promotes proliferation, migration, and invasion through regulating epithelial-mesenchymal transition in breast cancer cell lines | |
| Lin et al. | Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathway | |
| Yan et al. | LASP1 interacts with N-WASP to activate the Arp2/3 complex and facilitate colorectal cancer metastasis by increasing tumour budding and worsening the pattern of invasion | |
| Qu et al. | Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression | |
| CN104805197A (zh) | 分子标志物用于乳腺癌诊断和预后评估的方法 | |
| He et al. | HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition. | |
| Jiang et al. | Low FAT4 expression is associated with a poor prognosis in gastric cancer patients | |
| JP2015210268A5 (cg-RX-API-DMAC7.html) | ||
| Jeong et al. | Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion | |
| Zhai et al. | Overexpressed versican promoted cell multiplication, migration and invasion in gastric cancer | |
| Jin et al. | Endoplasmic reticulum–resident protein Sec62 drives colorectal cancer metastasis via MAPK/ATF2/UCA1 axis | |
| Zhang et al. | Long noncoding RNA ROR1‑AS1 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in cervical cancer. | |
| Wu et al. | B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway | |
| Wu et al. | Biomarkers of lymph node metastasis in esophageal cancer | |
| Wu et al. | Organoid models: applications and research advances in colorectal cancer | |
| CN107937520B (zh) | 与结直肠癌相关的分子标记物、抑制剂、试剂盒和药剂 | |
| Bahadoran et al. | Cytokeratin expression in breast cancer: from mechanisms, progression, diagnosis, and prognosis to therapeutic implications | |
| Li et al. | Overexpression of Aldo-keto reductase family 1 B10 protein in ductal carcinoma in situ of the breast correlates with HER2 positivity |